![Timothy Rothwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Rothwell
Presidente presso
EMISPHERE TECHNOLOGIES, INC.
Profilo
Timothy G.
Rothwell is Chairman at Emisphere Technologies, Inc. since 2012, Chairman at Speracura LLC since 2009, and Chairman at PhageNova Bio, Inc. Former roles include President & Chief Executive Officer at Sanofi-Synthelabo, Inc. from 2003 to 2004, Chief Executive Officer at Sandoz Pharmaceuticals Corp., Chairman at Archimedes Pharma Ltd., Chairman at Sanofi-Aventis U.S.
LLC from 2007 to 2009, Chairman at New American Therapeutics, Inc., Independent Director at Agenus, Inc. in 2011, Director at Akrimax Pharmaceuticals LLC, Somerset Medical Center, Inc., Pharmaceutical Research & Manufacturers of America, National Academy of Medicine (United States), and CEO Roundtable on Cancer, Inc., Director at PheoPara Alliance from 2009 to 2013, Senior Vice President-Marketing & Sales at Squibb Corp., President-Global Prescription Business & EVP at Pharmacia Corp.
from 1998 to 2003, Trustee-Corporate Council at The Children's Health Fund, Trustee at HealthCare Institute of New Jersey, President-Global Pharmaceutical Operations at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1995 to 1998, and Vice President-Global Marketing & Sales at Glaxo Wellcome, Inc. Education includes undergraduate studies at Drew University and graduate studies at Seton Hall University.
Posizioni attive di Timothy Rothwell
| Società | Posizione | Inizio |
|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Presidente | 18/09/2022 |
Speracura LLC | Presidente | 01/01/2009 |
PhageNova Bio, Inc.
 PhageNova Bio, Inc. BiotechnologyHealth Technology Develops gene therapy vectors | Presidente | - |
Precedenti posizioni note di Timothy Rothwell
| Società | Posizione | Fine |
|---|---|---|
PheoPara Alliance
 PheoPara Alliance Miscellaneous Commercial ServicesCommercial Services Engages in empowering and supporting of pheochromocytoma and paraganglioma patients | Presidente | - |
| AGENUS INC. | Direttore/Membro del Consiglio | 08/12/2011 |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Amministratore Delegato | 01/02/2007 |
Sanofi-Synthelabo, Inc. | Amministratore Delegato | 01/09/2004 |
Pharmacia Corp.
 Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/05/2003 |
Formazione di Timothy Rothwell
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
23
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 23 |
|---|---|
Drew University
 Drew University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Health Technology |
Squibb Corp.
 Squibb Corp. Pharmaceuticals: MajorHealth Technology Drug and personal care products | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Seton Hall University
 Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Health Fund
 The Children's Health Fund Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Somerset Medical Center, Inc.
 Somerset Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides medical and health care services | Health Services |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic and debilitating illnesses | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
CEO Roundtable on Cancer, Inc.
 CEO Roundtable on Cancer, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and promoting prevention measures and encouraging early detection through cancer screenings | Commercial Services |
Sanofi-Aventis U.S. LLC
Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Develops medicines, vaccines and provides specialized healthcare & clinical trail services | Health Technology |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024. | |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Glaxo Wellcome, Inc.
 Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
Sandoz Pharmaceuticals Corp. | |
New American Therapeutics, Inc.
 New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Health Technology |
PheoPara Alliance
PheoPara Alliance Miscellaneous Commercial ServicesCommercial Services Engages in empowering and supporting of pheochromocytoma and paraganglioma patients | Commercial Services |
Speracura LLC | |
PhageNova Bio, Inc.
PhageNova Bio, Inc. BiotechnologyHealth Technology Develops gene therapy vectors | Health Technology |
